Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder-Reference-Cited by-同舟云学术

Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder

Published:2021-06-01 Issue:5 Volume:31 Page:342-349
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Childress Ann C.¹,Kollins Scott H.²,Cutler Andrew J.³,Marraffino Andrea⁴,Sikes Carolyn R.⁵⁶

Affiliation:

1. Center for Psychiatry and Behavioral Medicine, Las Vegas, Nevada, USA.

2. Department of Psychiatry and Behavioral Science, Duke University, Durham, North Carolina, USA.

3. SUNY Upstate Medical University, Lakewood Ranch, Florida, USA.

4. Meridien Research, Orlando, Florida, USA.

5. Neos Therapeutics, Inc., Grand Prairie, Texas, USA.

6. Consultancy, Montclair, New Jersey, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2020.0142

Reference20 articles.

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.

2. Modifiers of Long-Term School Outcomes for Children with Attention-Deficit/Hyperactivity Disorder: Does Treatment with Stimulant Medication Make a Difference? Results from a Population-Based Study

3. The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study

4. Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Use of Dopamine Enhancers (Stimulants);Tasman’s Psychiatry;2024

2. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD);Cochrane Database of Systematic Reviews;2023-03-27

3. Therapeutic Use of Dopamine Enhancers (Stimulants);Tasman’s Psychiatry;2023

4. Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder;Advances in Pharmacology;2023